MyD88 and beyond: a perspective on MyD88-targeted therapeutic approach for modulation of host immunity.
Ontology highlight
ABSTRACT: The continuous emergence of infectious pathogens along with antimicrobial resistance creates a need for an alternative approach to treat infectious diseases. Targeting host factor(s) which are critically involved in immune signaling pathways for modulation of host immunity offers to treat a broad range of infectious diseases. Upon pathogen-associated ligands binding to the Toll-like/ IL-1R family, and other cellular receptors, followed by recruitment of intracellular signaling adaptor proteins, primarily MyD88, trigger the innate immune responses. But activation of host innate immunity strongly depends on the correct function of MyD88 which is tightly regulated. Dysregulation of MyD88 may cause an imbalance that culminates to a wide range of inflammation-associated syndromes and diseases.
SUBMITTER: Saikh KU
PROVIDER: S-EPMC8031343 | biostudies-literature | 2021 Apr
REPOSITORIES: biostudies-literature
ACCESS DATA